The study of Wnt/beta-catenin pathway involved in regulation of gastric cancer tumor microenvironment and its effect on immunosuppressive therapy

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000036846

Enrollment

Unknown

Registered

2020-08-25

Start date

2020-09-15

Completion date

Unknown

Last updated

2020-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastric cancer

Interventions

Wnt/ -catenin pathway activated and inactive groups:Use of immunotherapy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Gastric adenocarcinoma

Exclusion criteria

Exclusion criteria: Gastric squamous cell carcinoma, Gastric adenosquamous carcinoma, undifferentiated gastric carcinoma

Design outcomes

Primary

Measure	Time frame
Drug-sensitivity;	—

Countries

China

Contacts

Public ContactLei Wang

Fudan University Shanghai Cancer Center

wanglei056713@163.com+86 13564638960

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026